IQVIA Reports Strong Q1 Results, Raises Full-Year EPS Guidance, and Repurchases $552M in Stock
summarizeSummary
IQVIA reported robust first-quarter results, including an 8.4% revenue increase and a 7.4% rise in Adjusted Diluted EPS, leading to an upward revision of its full-year Adjusted Diluted EPS guidance. The company also repurchased $552 million of its common stock.
check_boxKey Events
-
Strong First Quarter Financial Performance
IQVIA reported first-quarter 2026 revenue of $4,151 million, an 8.4% increase year-over-year, and Adjusted Diluted Earnings per Share of $2.90, up 7.4% year-over-year. Free Cash Flow increased 15% year-over-year to $491 million.
-
Full-Year EPS Guidance Raised
The company raised its full-year 2026 guidance for Adjusted Diluted Earnings per Share to a range of $12.65 to $12.95, while reaffirming revenue and Adjusted EBITDA guidance.
-
Significant Share Repurchase Program
During the first quarter of 2026, IQVIA repurchased $552 million of its common stock, with $1,217 million of authorization remaining as of March 31, 2026.
-
Solid R&D Solutions Backlog and Bookings
Research & Development Solutions reported a contracted backlog of $34.2 billion and net new bookings of $2.5 billion, resulting in a book-to-bill ratio of 1.04x for the quarter.
auto_awesomeAnalysis
IQVIA Holdings Inc. delivered a strong first quarter, exceeding expectations with accelerated organic revenue growth and Adjusted Diluted EPS. The company's decision to raise its full-year Adjusted Diluted EPS guidance signals management's increased confidence in future profitability. Additionally, the substantial share repurchase program demonstrates a commitment to returning capital to shareholders and can be viewed as a positive signal regarding the company's valuation. Investors should monitor continued growth in R&D Solutions backlog and the execution of the share repurchase program.
At the time of this filing, IQV was trading at $152.50 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $27.3B. The 52-week trading range was $134.65 to $247.05. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.